Influence of glycosylphosphatidylinositol-linked H-2D(d) molecules on target cell protection and natural killer cell specificity in transgenic mice

被引:8
|
作者
Sentman, CL
OlssonAlheim, MY
Lendahl, U
Karre, K
机构
[1] KAROLINSKA INST, CTR MICROBIOL & TUMOR BIOL, STOCKHOLM, SWEDEN
[2] KAROLINSKA INST, DEPT CELL & MOL BIOL, STOCKHOLM, SWEDEN
关键词
natural killer cell; major histocompatibility complex class I; glycosylphosphatidylinositol; Ly49; transgenic mice;
D O I
10.1002/eji.1830260925
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The expression of certain major histocompatibility complex (MHC) class I ligands on target cells is one important determinate of their susceptibility to lysis by natural killer (NK) cells. NK cells express receptor molecules that bind to MHC class I. Upon binding to their MHC class I ligand, the NK cell is presumed to receive a signal through its receptor that inhibits lysis. It is unclear what role the MHC class I molecules of the effector and target cells play in signaling to the NK cell. We have investigated the role of the cytoplasmic and transmembrane domains of MHC class I molecules by producing a glycosylphosphatidylinositol (GPI)-linked H-2D(d) molecule. The GPI-linked H-2D(d) molecule is recognized by H-2D(d)-specific antibodies and cytotoxic T lymphocytes. Expression of the GPI-linked H-2D(d) molecule on H-2(b) tumor cells resulted in protection of the tumor cells after transplantation into D8 mice (H-2(b), H-2D(d)) from rejection by NK cells. In addition, NK cells from mice expressing the GPI-linked H-2D(d) molecule as a transgene were able to kill nontransgenic H-2(b) lymphoblast target cells. The GPI-linked MHC class I molecule was able to alter NK cell specificity at the target and effector cell levels. Thus, the expression of the cytoplasmic and transmembrane domains of MHC class I molecules are not necessary for protection and alteration of NK cell specificity.
引用
收藏
页码:2127 / 2132
页数:6
相关论文
共 50 条
  • [1] H-2D(p) transgene alters natural killer cell specificity at the target and effector cell levels - Comparison with an H-2D(d) transgene
    Sentman, CL
    OlssonAlheim, MY
    Lendahl, U
    Karre, K
    JOURNAL OF IMMUNOLOGY, 1996, 156 (07): : 2423 - 2429
  • [2] ALTERATION OF THE NATURAL-KILLER REPERTOIRE IN H-2 TRANSGENIC MICE - SPECIFICITY OF RAPID LYMPHOMA CELL CLEARANCE DETERMINED BY THE H-2 PHENOTYPE OF THE TARGET
    HOGLUND, P
    GLAS, R
    OHLEN, C
    LJUNGGREN, HG
    KARRE, K
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (02): : 327 - 334
  • [3] THE H-2D GENES INFLUENCE EXPRESSION OF HLA-B27 IN TRANSGENIC MICE
    NICKERSON, CL
    DAVID, CS
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 421 - 422
  • [4] NATURAL-KILLER-CELLS RECOGNIZE COMMON ANTIGENIC MOTIFS SHARED BY H-2D(D), H-2L(D) AND POSSIBLY H-2D(R) MOLECULES EXPRESSED ON BONE-MARROW CELLS
    YU, YYL
    FORMAN, J
    ALDRICH, C
    BLAZAR, B
    FLAHERTY, L
    KUMAR, V
    BENNETT, M
    INTERNATIONAL IMMUNOLOGY, 1994, 6 (09) : 1297 - 1306
  • [5] REJECTION OF BONE-MARROW CELL ALLOGRAFTS BY NATURAL-KILLER-CELL SUBSETS - 5E6+ CELL SPECIFICITY FOR HH-1 DETERMINANT 2 SHARED BY H-2D AND H-2F
    SENTMAN, CL
    KUMAR, V
    BENNETT, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (11) : 2821 - 2828
  • [6] EVIDENCE FOR MULTIPLE I-E MOLECULES IN H-2D TUMOR-CELL LINES
    SINGH, SK
    LAFUSE, WP
    MCKEAN, DJ
    DAVID, CS
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 612 - 612
  • [7] Glycosylphosphatidylinositol-anchored H-2D(b) molecules are defective in antigen processing and presentation to cytotoxic T lymphocytes
    Cariappa, A
    Flyer, DC
    Rollins, CT
    Roopenian, DC
    Flavell, RA
    Brown, D
    Waneck, GL
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (09) : 2215 - 2224
  • [8] EXPRESSION OF HLA-B27 IN TRANSGENIC MICE IS CONTROLLED BY THE H-2D GENE(S)
    NICKERSONNUTTER, CL
    DAVID, CS
    INTERNATIONAL JOURNAL OF CANCER, 1991, : 14 - 17
  • [9] EXPRESSION OF HLA-B27 IN TRANSGENIC MICE IS DEPENDENT ON THE MOUSE H-2D GENES
    NICKERSON, CL
    HANSON, J
    DAVID, CS
    JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (04): : 1255 - 1261
  • [10] SH2D2A Modulates T Cell Mediated Protection to a B Cell Derived Tumor in Transgenic Mice
    Berge, Tone
    Gronningsaeter, Ingrid Helene Bo
    Lorvik, Kristina Berg
    Abrahamsen, Greger
    Granum, Stine
    Sundvold-Gjerstad, Vibeke
    Corthay, Alexandre
    Bogen, Bjarne
    Spurkland, Anne
    PLOS ONE, 2012, 7 (10):